Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000047

Chief Operating Officer sold 7,097 shares at an average $18.03 ($127,938)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dowden Nathan J Chief Operating Officer 2023-07-10 Sale 10b5-1 −3,200 $18.00 $57,605 39,273 D: show line 1 in the form
Dowden Nathan J Chief Operating Officer 2023-07-11 Sale 10b5-1 −3,897 $18.05 $70,333 35,376 D: show line 2 in the form
Open-market sales · 7,097 sh · avg $18.03 · $127,938
Loading xslF345X04/wf-form4_168919399033901.xml…